Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil

Tropical Medicine and International Health

Volumn 17, Issue 11, 2012, Pages 1349-1355

  De Melo Inagaki, Ana Dorcas ^a   Carvalheiro, Cristina Gardonyi ^b   Cipolotti, Rosana ^a   Gurgel, Ricardo Queiroz ^a   Rocha, Dayse Alves ^a   Pinheiro, Kariny Souza ^c   Araújo, Raquel Melo ^a   Lima, Dorothy Ribeiro Resende ^d   Winandy, Jacques Leon ^e   Mussi Pinhata, Marisa Márcia ^b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Centre of Hemotherapy and Central Laboratory of Public Health of Sergipe   (Brazil)

^d Ophthalmology Service   (Brazil)

^e Nossa Senhora de Lourdes Maternity   (Brazil)

Author keywords

Congenital toxoplasmosis; Heel prick test; Neonatal screening; Perinatal infections; Toxoplasma gondii

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE; SULFADIAZINE;

ANTIBODY; BIRTH RATE; BLOOD; CHILD HEALTH; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE TREATMENT; DRUG; EYE DISEASE; LESION; MENTAL HEALTH; NEONATE; PARASITIC DISEASE; PROTOZOAN; SYMPTOM;

ARTICLE; ASYMPTOMATIC INFECTION; BLOOD SAMPLING; BRAIN CALCIFICATION; BRAZIL; CHORIORETINOPATHY; CLINICAL FEATURE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; EVALUATION AND FOLLOW UP; EYE INJURY; FEMALE; HUMAN; IMMUNOASSAY; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PREVALENCE; TOXOPLASMA GONDII;

CONGENITAL TOXOPLASMOSIS; CRIBADO NEONATAL; DÉPISTAGE NÉONATAL; HEEL PRICK TEST; INFECCIONES PERINATALES; INFECTIONS PÉRINATALES; NEONATAL SCREENING; PERINATAL INFECTIONS; PRUEBA DEL TALÓN; TEST DE GUTHRIE; TOXOPLASMA GONDII; TOXOPLASMOSE CONGÉNITALE; TOXOPLASMOSIS CONGÉNITA;

ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; BRAZIL; HUMANS; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; LEUCOVORIN; NEONATAL SCREENING; PYRIMETHAMINE; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

BRAZIL; SERGIPE;

TOXOPLASMA GONDII;

EID: 84867908901     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03079.x     Document Type: Article

References (25)

1. Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, De Souza CB & Maciel LM (2005) Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiology and Infection 133, 485-491.
2. Detanico L & Basso RMC (2006) [Toxoplasmose: perfil sorológico de mulheres em idade fértil e gestantes.]. Revista Brasileira de Análises Clínicas 38, 15-18.
3. Evengård B, Petersson K, Engman ML et al. (2001) Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiology and Infection 127, 121-127.
4. Figueiró-Filho EA, Senefonte FR, Lopes AH et al. (2007) [Frequency of HIV-1, rubella, syphilis, toxoplasmosis, cytomegalovirus, simple herpes virus, hepatitis B, hepatitis C, Chagas disease and HTLV I/II infection in pregnant women of State of Mato Grosso do Sul.]. Revista da Sociedade Brasileira de Medicina Tropical 40, 181-187.
5. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M & Petersen E (2007) Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. Journal of Medical Screening 14, 8-13.
6. Gilbert RE, Freeman K, Lago EG et al. (2008) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Neglected Tropical Diseases 2, e277.
7. Gómez-Marin JE, de-la-Torre A, Angel-Muller E et al. (2011) First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Neglected Tropical Diseases 5, e1195.
8. Guerina NG, Hsu HW, Meissner HC et al. (1994) Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. The New England Journal of Medicine 330, 1858-1863.
9. Gurgel RQ, Nery AMDG, Almeida MLD et al. (2009) [Characteristics of pregnancies, deliveries and newborns in the metropolitan region of Aracaju, State of Sergipe, Brazil]. Revista Brasileira de Saúde Materno Infantil 9, 167-177.
10. Inagaki AD, Oliveira LA, Oliveira MF et al. (2009) [Seroprevalence of antibodies for toxoplasmosis, rubella, cytomegalovirus, syphilis and HIV among pregnant women in Sergipe]. Revista da Sociedade Brasileira de Medicina Tropical 42, 532-536.
11. Jones JL, Kruszon-Moran D, Sanders-Lewis K & Wilson M (2007) Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. The American Journal of Tropical Medicine and Hygiene 77, 405-410.
12. Lago EG, Neto EC, Melamed J et al. (2007) Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatric and Perinatal Epidemiology 21, 525-531.
13. Lebech M, Joynson DH, Seitz HM et al. (1996) Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. European Journal of Clinical Microbiology & Infectious Diseases 15, 799-805.
14. Lebech M, Andersen O, Christensen NC et al. (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353, 1834-1837.
15. McAuley J, Boyer KM, Patel D et al. (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clinical Infectious Diseases 18, 38-72.
16. Montoya JG & Liesenfeld O (2004) Toxoplasmosis. Lancet 363, 1965-1976.
17. Montoya JG & Rosso F (2005) Diagnosis and management of toxoplasmosis. Clinics in Perinatology 32, 705-726.
18. Neto EC, Amorim F & Lago EG (2010) Estimation of the regional distribution of congenital toxoplasmosis in Brazil from the results of neonatal screening. Scientia Medica 20, 64-70.
19. Petersen E (2007) Toxoplasmosis. Seminars in Fetal & Neonatal Medicine 12, 214-223.
20. Robert-Gangneux F (2001) Contribution of new techniques for the diagnosis of congenital toxoplasmosis. Clinical Laboratory 47, 135-141.
21. Rodrigues IM, Castro AM, Gomes MB, Amaral WN & Avelino MM (2009) Congenital toxoplasmosis: evaluation of serological methods for the detection of anti-Toxoplasma gondii IgM and IgA antibodies. Memórias do Instituto Oswaldo Cruz 104, 434-440.
22. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H & Petersen E (2006) The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Archives of Disease in Childhood 91, 661-665.
23. SYROCOT (Systematic Review On Congenital Toxoplasmosis) Study Group (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369, 115-122.
24. Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR et al. (2009) Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 116, 2199-2205.
25. Villena I, Ancelle T, Delmas C et al. (2010) Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Eurosurveillance 15, 1-6.